SARS‑CoV‑2 questions on Step exams rarely want you to regurgitate a timeline—they want you to recognize patterns: an enveloped +ssRNA virus with spike‑mediated entry, a distinctive immune response (including cytokine storm), and a disease spectrum tied to age/comorbidities and vaccination status. Here’s a quick-hit, shareable set of tables + mnemonics + one‑liners to lock in the highest yield facts.
10‑second identity (what you must know cold)
SARS‑CoV‑2 is a Coronavirus: enveloped, positive‑sense single‑stranded RNA virus that replicates in the cytoplasm and uses ACE2 for cell entry.
One-liner: “Enveloped +ssRNA coronavirus that uses ACE2 via Spike and can cause anything from anosmia to ARDS via diffuse alveolar damage.”
Visual mnemonic: “CROWN with a KEY”
Picture a crown (corona) with a key:
- CROWN = Coronavirus envelope studs (spikes)
- KEY = Spike (S) protein is the key that unlocks ACE2
- Door hinges = TMPRSS2 helps prime Spike for fusion/entry (high yield association)
One-liner: “Spike is the key, ACE2 is the lock, TMPRSS2 helps turn the key.”
Comparison Table #1: Virology basics (SARS‑CoV‑2 vs classic high‑yield viruses)
| Feature | SARS‑CoV‑2 (Coronavirus) | Influenza A (Orthomyxovirus) | RSV (Paramyxovirus) | Adenovirus |
|---|---|---|---|---|
| Genome | +ssRNA | –ssRNA, segmented | –ssRNA | dsDNA |
| Envelope | Enveloped | Enveloped | Enveloped | Non‑enveloped |
| Replication site | Cytoplasm | Nucleus (exception for RNA viruses) | Cytoplasm | Nucleus |
| Key surface protein | Spike (S) | HA/NA | F protein | Fiber protein |
| Entry receptor | ACE2 (plus cofactors like TMPRSS2) | Sialic acid | Heparan sulfate (varies) | CAR receptor |
| Notable mechanism | Spike-mediated fusion/endocytosis | Antigenic drift/shift | Syncytia via F | Lytic infection; conjunctivitis |
| Typical “testable” clinical clue | Anosmia/ageusia, hypoxemia, ground-glass opacities | Abrupt fever + myalgias | Bronchiolitis in infants | Pharyngoconjunctival fever |
Comparison Table #2: Structural + genomics “buzzwords” that show up in stems
| High-yield fact | What it means | How it appears on USMLE |
|---|---|---|
| +ssRNA genome | Can function as mRNA | Rapid replication; cytoplasmic lifecycle |
| Enveloped virus | Lipid membrane | Inactivated by detergents/soap; less stable on surfaces vs non-enveloped (but still transmissible) |
| Spike (S) protein | Binds receptor + mediates entry | Target of neutralizing antibodies; vaccines largely aim here |
| ACE2 receptor | Highly expressed in respiratory epithelium (also GI, endothelium) | Respiratory + GI symptoms; vascular complications |
| Cytokine-driven injury | Dysregulated host response | ARDS, shock, elevated inflammatory markers |
| Hypercoagulability | Endothelial activation/inflammation | DVT/PE risk; microthrombi; severe hypoxemia |
One-liners you can drop into any question
- Transmission: “Primarily respiratory—droplets/aerosols in close contact settings.”
- Incubation: “Often a few days; asymptomatic transmission is a classic clue.”
- Core pulmonary pathology in severe disease: Diffuse alveolar damage → ARDS (hyaline membranes).
- Classic imaging buzzword: Ground-glass opacities (nonspecific but commonly tested).
- Anosmia/ageusia: early clue pointing you toward SARS‑CoV‑2 over “generic viral URI.”
- Multisystem complications: “Not just pneumonia—think thrombosis + inflammation + end-organ dysfunction.”
Pathogenesis flow (Step-friendly)
- Entry: Spike binds ACE2 (primed by proteases like TMPRSS2)
- Replication: Cytoplasmic replication → viral production
- Local disease: Upper → lower respiratory tract involvement
- Severe disease (host response):
- Diffuse alveolar damage → ARDS
- Endothelial inflammation → hypercoagulability (microthrombi, PE)
- Systemic inflammation → shock, organ injury
Clinical spectrum: quick comparison table
| Category | Typical features | High-yield exam twist |
|---|---|---|
| Mild/moderate | Fever, cough, sore throat, fatigue, anosmia/ageusia, GI symptoms | Many are mild; don’t overcall pneumonia |
| Severe pulmonary | Dyspnea, hypoxemia, diffuse infiltrates | ARDS physiology (refractory hypoxemia) |
| Thrombotic | DVT/PE, stroke, microvascular thrombosis | Clues: sudden worsening hypoxemia, pleuritic CP, unilateral leg swelling |
| Pediatric inflammatory | Fever + systemic inflammation after infection | Think MIS‑C style presentation (post-infectious hyperinflammation) |
Diagnostics: what the test writers expect
| Test | Detects | When it’s useful | High-yield pitfall |
|---|---|---|---|
| NAAT/PCR | Viral RNA | Acute infection | Most sensitive early; sampling matters |
| Antigen test | Viral proteins | Quick, best with higher viral load | More false negatives vs NAAT |
| Serology | Antibodies | Prior infection/vaccine response (context dependent) | Not for diagnosing early acute infection |
Treatment & prevention (Step-relevant framing)
Most tested concept: Supportive care + oxygen escalation for hypoxemia; antivirals/immunomodulation depend on severity and timing.
- Supportive: oxygen, fluids as needed, manage complications
- Severe inflammatory lung disease: immunomodulation may be used in hospitalized patients with significant oxygen needs (concept: treat the host inflammatory phase)
- Prevention: vaccination reduces severe disease risk; enveloped virus → soap/hand hygiene is effective
(On exams, you’re more likely to be tested on “who gets severe disease and why” and “what complication is happening” than memorizing specific brand-name regimens.)
Micro “rapid-fire” mnemonics (print-and-share style)
1) “Corona = Cytoplasm”
One-liner: “Coronavirus is an RNA virus that replicates in the cytoplasm (unlike influenza).”
2) “Spike → Smell loss”
One-liner: “Spike-mediated ACE2 entry + upper airway involvement: think anosmia/ageusia.”
3) “COVID CLOTTING”
One-liner: “Inflammation + endothelial injury → hypercoagulability (DVT/PE/microthrombi).”
Ultra-high-yield “Step stem” patterns to recognize
- Enveloped RNA virus + ground-glass opacities + anosmia → SARS‑CoV‑2
- Worsening hypoxemia out of proportion + signs of thrombosis → consider PE/microthrombi
- Severe respiratory failure with diffuse infiltrates → ARDS from diffuse alveolar damage
- Aerosol spread in indoor/crowded settings + asymptomatic transmission → classic public health angle
Quick recap table (the “sticky note”)
| Must-know | Answer |
|---|---|
| Virus family | Coronavirus |
| Genome | +ssRNA |
| Envelope | Yes |
| Replication | Cytoplasm |
| Entry | Spike → ACE2 (TMPRSS2 helps) |
| Key complications | ARDS, thrombosis, systemic inflammation |
| Classic clues | Anosmia/ageusia, ground-glass opacities |